N-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen

C70H79ClF5N21O2S3 — CID 159121285

IUPACN-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen
SMILESCc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(Sc3ccc(C(=O)NCC(F)(F)F)cc3)n2)n[nH]1.Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(Sc3ccc4ccccc4c3)n2)n[nH]1.Cc1cc(Nc2cc(N3CCC3)nc(Sc3ccc(NC(=O)c4ccccc4Cl)nc3)n2)n[nH]1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C24H23FN6S.C23H21ClN8OS.C23H23F4N7OS.6H2/c1-15-10-21(30-29-15)26-20-12-22(31-13-24(25,14-31)18-7-8-18)28-23(27-20)32-19-9-6-16-4-2-3-5-17(16)11-19;1-14-11-20(31-30-14)26-19-12-21(32-9-4-10-32)29-23(28-19)34-15-7-8-18(25-13-15)27-22(33)16-5-2-3-6-17(16)24;1-13-8-18(33-32-13)29-17-9-19(34-11-22(24,12-34)15-4-5-15)31-21(30-17)36-16-6-2-14(3-7-16)20(35)28-10-23(25,26)27;;;;;;/h2-6,9-12,18H,7-8,13-14H2,1H3,(H2,26,27,28,29,30);2-3,5-8,11-13H,4,9-10H2,1H3,(H,25,27,33)(H2,26,28,29,30,31);2-3,6-9,15H,4-5,10-12H2,1H3,(H,28,35)(H2,29,30,31,32,33);6*1H
InChIKeyKFSLISXOHLNCAP-UHFFFAOYSA-N
MW1473.19 g/mol
LogP16.52
Rot. Bonds21

About N-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen

N-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen (PubChem CID 159121285) has the molecular formula C70H79ClF5N21O2S3 and a molecular weight of 1473.19 g/mol. Its IUPAC name is N-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen.

Molecular Properties

Compound NameN-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen
PubChem CID159121285
Molecular FormulaC70H79ClF5N21O2S3
Molecular Weight1473.19 g/mol
Exact Mass1471.55
IUPAC NameN-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen
SMILESCc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(Sc3ccc(C(=O)NCC(F)(F)F)cc3)n2)n[nH]1.Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(Sc3ccc4ccccc4c3)n2)n[nH]1.Cc1cc(Nc2cc(N3CCC3)nc(Sc3ccc(NC(=O)c4ccccc4Cl)nc3)n2)n[nH]1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C24H23FN6S.C23H21ClN8OS.C23H23F4N7OS.6H2/c1-15-10-21(30-29-15)26-20-12-22(31-13-24(25,14-31)18-7-8-18)28-23(27-20)32-19-9-6-16-4-2-3-5-17(16)11-19;1-14-11-20(31-30-14)26-19-12-21(32-9-4-10-32)29-23(28-19)34-15-7-8-18(25-13-15)27-22(33)16-5-2-3-6-17(16)24;1-13-8-18(33-32-13)29-17-9-19(34-11-22(24,12-34)15-4-5-15)31-21(30-17)36-16-6-2-14(3-7-16)20(35)28-10-23(25,26)27;;;;;;/h2-6,9-12,18H,7-8,13-14H2,1H3,(H2,26,27,28,29,30);2-3,5-8,11-13H,4,9-10H2,1H3,(H,25,27,33)(H2,26,28,29,30,31);2-3,6-9,15H,4-5,10-12H2,1H3,(H,28,35)(H2,29,30,31,32,33);6*1H
InChIKeyKFSLISXOHLNCAP-UHFFFAOYSA-N
XLogP16.52
TPSA280.28 Ų
H-Bond Donors8
H-Bond Acceptors21
Rotatable Bonds21
Heavy Atoms102
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001473.19
LogP ≤ 516.52
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1021

Analyze N-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen?
The IUPAC name of N-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen (CID 159121285) is N-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen.
What is the SMILES notation for N-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen?
The canonical SMILES for N-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen is Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(Sc3ccc(C(=O)NCC(F)(F)F)cc3)n2)n[nH]1.Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(Sc3ccc4ccccc4c3)n2)n[nH]1.Cc1cc(Nc2cc(N3CCC3)nc(Sc3ccc(NC(=O)c4ccccc4Cl)nc3)n2)n[nH]1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].
What is the InChIKey of N-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen?
The InChIKey is KFSLISXOHLNCAP-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H23FN6S.C23H21ClN8OS.C23H23F4N7OS.6H2/c1-15-10-21(30-29-15)26-20-12-22(31-13-24(25,14-31)18-7-8-18)28-23(27-20)32-19-9-6-16-4-2-3-5-17(16)11-19;1-14-11-20(31-30-14)26-19-12-21(32-9-4-10-32)29-23(28-19)34-15-7-8-18(25-13-15)27-22(33)16-5-2-3-6-17(16)24;1-13-8-18(33-32-13)29-17-9-19(34-11-22(24,12-34)15-4-5-15)31-21(30-17)36-16-6-2-14(3-7-16)20(35)28-10-23(25,26)27;;;;;;/h2-6,9-12,18H,7-8,13-14H2,1H3,(H2,26,27,28,29,30);2-3,5-8,11-13H,4,9-10H2,1H3,(H,25,27,33)(H2,26,28,29,30,31);2-3,6-9,15H,4-5,10-12H2,1H3,(H,28,35)(H2,29,30,31,32,33);6*1H.
What are the key properties of N-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen?
N-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen has a molecular weight of 1473.19 g/mol, XLogP of 16.52, 21 rotatable bonds, 8 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-2-pyridinyl]-2-chlorobenzamide;4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)benzamide;6-(3-cyclopropyl-3-fluoroazetidin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylsulfanylpyrimidin-4-amine;molecular hydrogen is sourced from PubChem (CID 159121285), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).